Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “dcSSc”

85 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 85 results

Early research (Phase 1)Ended earlyNCT04478994
What this trial is testing

A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Amgen 3
Testing effectiveness (Phase 2)Study completedNCT03222492
What this trial is testing

Brentuximab Vedotin for Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic SclerosisSclerodermadcSSc
National Institute of Allergy and Infectious Diseases (NIAID) 17
Testing effectiveness (Phase 2)Study completedNCT01538719
What this trial is testing

IL1-TRAP, Rilonacept, in Systemic Sclerosis

Who this might be right for
SclerodermaSystemic SclerosisDiffuse Scleroderma+1 more
Boston University 24
Testing effectiveness (Phase 2)Study completedNCT02503644
What this trial is testing

Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Scleroderma, DiffuseDiffuse Cutaneous Systemic Sclerosis
Inventiva Pharma 145
Not applicableLooking for participantsNCT07000916
What this trial is testing

Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults

Who this might be right for
Juvenile Idiopathic ArthritisRheumatoid ArthritisPsoriatic Arthritis+3 more
Université Catholique de Louvain 1,000
Testing effectiveness (Phase 2)Study completedNCT00442611
What this trial is testing

Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)

Who this might be right for
Scleroderma, DiffuseScleroderma, Systemic
Stanford University 10
Early research (Phase 1)Not Yet RecruitingNCT07490275
What this trial is testing

Allogeneic CD19/BCMA-Targeted CAR-γδT Cell Therapy: Safety and Preliminary Pharmacodynamics in Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Refractory/Relapsed Systemic Lupus ErythematosusRefractory / Relapsed / Progressive Systemic SclerosisRefractory / Relapsing / Progressive Inflammatory Myopathy+2 more
Institute of Hematology & Blood Diseases Hospital, China
Testing effectiveness (Phase 2)Active Not RecruitingNCT02682511
What this trial is testing

Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension

Who this might be right for
Scleroderma, DiffuseScleroderma, SystemicScleroderma, Limited+5 more
Cumberland Pharmaceuticals 34
Testing effectiveness (Phase 2)Ended earlyNCT01545427
What this trial is testing

Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma

Who this might be right for
Scleroderma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 10
Testing effectiveness (Phase 2)Looking for participantsNCT03844061
What this trial is testing

Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Hospital for Special Surgery, New York 30
Not applicableAvailableNCT04432545
What this trial is testing

Infusion of Allogeneic Mesenchymal Stem Cells in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement

Who this might be right for
Systemic Sclerosis PulmonaryPulmonary HypertensionPulmonary Fibrosis
Universidad de la Sabana
Testing effectiveness (Phase 2)Study completedNCT04647890
What this trial is testing

Effects of FT011 in Systemic Sclerosis

Who this might be right for
Scleroderma, SystemicScleroderma, DiffuseSclerosis, Systemic
Certa Therapeutics 30
Post-approval studies (Phase 4)Study completedNCT07472166
What this trial is testing

Efficacy of Tofacitinib on Skin Thickening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate

Who this might be right for
Scleroderma, Systemic
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 34
Testing effectiveness (Phase 2)Study completedNCT00879658
What this trial is testing

Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Novartis Pharmaceuticals 297
Very early researchLooking for participantsNCT07355972
What this trial is testing

Safety, Efficacy and Cellular Metabolic Dynamics of CT1195E in Patients With Refractory / Progressive SSC

Who this might be right for
SSc-Systemic Sclerosis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 12
Early research (Phase 1)Active Not RecruitingNCT06152172
What this trial is testing

CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101

Who this might be right for
Idiopathic Inflammatory MyopathiesDiffuse Cutaneous Systemic SclerosisSLE Nephritis+1 more
David Porter 24
Testing effectiveness (Phase 2)Study completedNCT07542067
What this trial is testing

Infusion of Allogeneic Stromal Mesenchymal Stem Cells From Wharton´s Jelly in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement to Treatment

Who this might be right for
Systemic Sclerosis PulmonaryPulmonary HypertensionPulmonary Fibrosis
Fundación Neumologica Colombiana 1
Large-scale testing (Phase 3)Ended earlyNCT03398837
What this trial is testing

Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Corbus Pharmaceuticals Inc. 365
Testing effectiveness (Phase 2)Study completedNCT03041025
What this trial is testing

Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Scleroderma, Systemic
GlaxoSmithKline 35
Testing effectiveness (Phase 2)Study completedNCT02370784
What this trial is testing

Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma

Who this might be right for
Scleroderma
Robyn T. Domsic, MD, MPH 24
Next Page
9